Home
Conditions
Polypoidal Choroidal Vasculopathy

Clinical trial condition

Polypoidal Choroidal Vasculopathy

Explore clinical trials studying Polypoidal Choroidal Vasculopathy. Study availability and eligibility vary by location and protocol.

29 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Polypoidal Choroidal Vasculopathy trial results

Completed

Assessment of Visual Acuity in Patients With Polypoidal Choroidal Vasculopathy and Aflibercept Treatment

NCT02381730

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +6 more
Locations: CHU Lyon Croix Rousse Lyon, France

Fondation Ophtalmologique A. de Rothschild Paris, France

Centre Médical de la Rétine Maison Rouge Strasbourg, France

View Trial Details

Completed

Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)

NCT01884597

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +7 more
Locations: Retina Consultants of Hawaii Honolulu, Hawaii, United States

Retina Consultants of Hawaii ‘Aiea, Hawaii, United States

The Retina Center at Pali Momi ‘Aiea, Hawaii, United States

View Trial Details

Completed

Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation

NCT01871376

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +6 more
Locations: Retina Consultants of Hawaii ‘Aiea, Hawaii, United States

View Trial Details

Completed

Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy

NCT01950741

Conditions: Choroid Diseases, Choroidal Neovascularization, Exudative Age-Related Macular Degeneration, +7 more
Locations: Busan Paik Hospital Busanjin-gu, Busan, South Korea

Haeundae Paik Hospital Haeundae, Busan, South Korea

Gospel Hospital Seo-gu, Busan, South Korea

Pusan National University Hospital Seo-gu, Busan, South Korea

View Trial Details

Completed

Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)

NCT00424710

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +6 more
Locations: Retina Consultants of Hawaii Honolulu, Hawaii, United States

The Retina Center at Pali Momi ‘Aiea, Hawaii, United States

View Trial Details

Completed

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

NCT00470977

Conditions: Abnormalities, Multiple, Angiomatosis, BEST VITELLIFORM MACULAR DYSTROPHY, MULTIFOCAL (Disorder), +45 more
Locations: Lenox Hill Hospital/Manhattan Eye Ear and Throat Institute New York, United States

Lenox Hill Hospital/Manhattan Eye, Ear & Throat Institute New York, United States

View Trial Details

Completed

Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)

NCT01023295

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +6 more
Locations: OXiGENE Investigational Site Los Angeles, California, United States

OXiGENE Investigational Site Hong Kong

OXiGENE Investigational Site Singapore

OXiGENE Investigational Site Seoul, South Korea

View Trial Details

Completed

Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy

NCT00674323

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +11 more
Locations: Novartis Investigative Site Hong Kong

Novartis Investigative Site Singapore

Novartis Investigative Site Seoul, South Korea

Novartis Investigative Site Taipei, Taiwan

View Trial Details

Completed

Response to Ranibizumab in Polypoidal Choroidal Vasculopathy (PCV)and SNPs

NCT01271426

Conditions: Choroid Diseases, Choroidal Neovascularization, Eye Diseases, +6 more
Locations: Surugadai Nihon university hospital 1-8-13 Kandasurugadai Chiyoda-ku, Tokyo, Japan

View Trial Details

Polypoidal Choroidal Vasculopathy

Polypoidal Choroidal Vasculopathy trial results

Related conditions